Merck Projects Lower 2025 Earnings Amid Vaccine Shipment Pause

New York, Tuesday, 4 February 2025.
Merck’s 2025 earnings forecast, at $64.1-$65.6 billion, falls short of analyst expectations due to halted HPV vaccine shipments to China, impacting revenue negatively.